Riyadh - Sharikat Mubasher: Saudi Arabia’s Ministry of Health is set to launch the first edition of BIO Middle East, the leading biotechnology event in the region, from 11 to 13 May 2026.
Co-locating with CPHI Middle East, the region's leading pharmaceutical event, BIO Middle East will gather global leaders, innovators, and investors, serving as a world-class platform for partnership and innovation, a recent statement revealed.
The BIO Middle East exhibition and conference will feature high-level panel discussions with global industry leaders, company showcases of the latest biotech innovations, specialized workshops, and networking opportunities connecting investors and researchers to strengthen global partnerships.
This first-of-its-kind event underscores Saudi Arabia’s commitment to becoming a regional and global hub for pharmaceuticals and life sciences.
The event is expected to stimulate job creation within the Saudi health sector, attract foreign investment, and promote the development of innovative medical solutions that serve local and regional communities.
The Saudi Minister of Health, Fahad Aljalajel, stated that the launch of BIO Middle East marks a significant milestone as the Kingdom establishes itself as a global hub for biotechnology and life sciences innovation. “This event embodies Vision 2030’s commitment to building an advanced health ecosystem grounded in scientific research and international partnerships, with the aim of developing innovative solutions that serve our citizens, the region, and contribute to humanity worldwide,” he said.
Organized by Tahaluf, a strategic alliance between Informa PLC, the Saudi Federation for Cyber Security and Programming (SAFCSP), and the Events Investment Fund (EIF), BIO Middle East will be the central platform for collaboration, investment, and knowledge exchange, aligning with the goals of Vision 2030 and the National Biotechnology Strategy.
Mike Champion, CEO of Tahaluf, commented: “We at Tahaluf are proud to partner with the Saudi Ministry of Health to organize this landmark event. We are confident that it will catalyze the growth of the biopharmaceutical industry across the Middle East and empower entrepreneurs and scientists to make a meaningful impact.”
Moreover, BIO Middle East will offer participants an unparalleled opportunity to connect with the entire life sciences value chain, expand their networking opportunities, and provide a holistic view of the pharma and biotech landscape.
